E-LIB Suche - Ergebnisse für: Ohashi, Kadoaki

1

Severe Cytokine Release Syndrome and Immune Effector Cell-a..:

Tanaka, Takaaki ; Taoka, Masataka ; Makimoto, Go...
Internal Medicine. 63 (2024) 9 - p. 1261-1267 , 2024

Link: https://doi.org/10.2169/..

2

Phase 2 trial of crizotinib in Japanese patients with advan..:

Nosaki, Kaname ; Yoh, Kiyotaka ; Toyozawa, Ryo...
International Journal of Clinical Oncology. , 2024

Link: https://doi.org/10.1007/..

3

A Prompt Diagnosis and Treatment of a Case of Nuclear Prote..:

Matsuura, Hiroaki ; Makimoto, Go ; Oda, Naohiro...
Internal Medicine. , 2024

Link: https://doi.org/10.2169/..

4

Clinical characteristics of patients treated with immune ch..:

Kuribayashi, Tadahiro ; Ohashi, Kadoaki ; Nishii, Kazuya...
Journal of Cancer Research and Clinical Oncology. 150 (2024) 2 - p. , 2024

Link: https://doi.org/10.1007/..

5

Clinical outcomes in patients with non-small cell lung canc..:

Okahisa, Masanobu ; Udagawa, Hibiki ; Matsumoto, Shingo...
Lung Cancer. 191 (2024) - p. 107798 , 2024

Link: https://doi.org/10.1016/..

6

Concomitant osimertinib and antituberculosis therapy in an ..:

Matsuura, Hiroaki ; Higo, Hisao ; Kuribayashi, Tadahiro...
Thoracic Cancer. 15 (2024) 17 - p. 1390-1394 , 2024

Link: https://doi.org/10.1111/..

7

Efficacy of gilteritinib in comparison with alectinib for t..:

Ando, Chihiro ; Ichihara, Eiki ; Nishi, Tatsuya...
Cancer Science. 114 (2023) 11 - p. 4343-4354 , 2023

Link: https://doi.org/10.1111/..

8

Pembrolizumab plus chemotherapy in Japanese patients with m..:

Sugawara, Shunichi ; Tanaka, Kentaro ; Imamura, Fumio...
Cancer Science. 114 (2023) 8 - p. 3330-3341 , 2023

Link: https://doi.org/10.1111/..

9

Low frequency of intracranial progression in advanced NSCLC..:

Kemmotsu, Naoya ; Ninomiya, Kiichiro ; Kunimasa, Kei...
International Journal of Cancer. 154 (2023) 1 - p. 169-179 , 2023

Link: https://doi.org/10.1002/..

10

Cutaneous toxicity with subepidermal blisters and dyskerato..:

Yokomizo, Sayuri ; Miyake, Tomoko ; Kawakami, Yoshio...
The Journal of Dermatology. 51 (2023) 2 - p. , 2023

Link: https://doi.org/10.1111/..

11

PD-1 blockade augments CD8+ T cell dependent antitumor immu..:

Nakasuka, Takamasa ; Ohashi, Kadoaki ; Nishii, Kazuya...
Lung Cancer. 178 (2023) - p. 1-10 , 2023

Link: https://doi.org/10.1016/..

12

Clinicogenomic Features and Targetable Mutations in NSCLCs ..:

Sakai, Tetsuya ; Matsumoto, Shingo ; Ueda, Yasuto...
Journal of Thoracic Oncology. 18 (2023) 11 - p. 1538-1549 , 2023

Link: https://doi.org/10.1016/..

13

Pulmonary Aspergilloma and Allergic Bronchopulmonary Asperg..:

Ando, Eri ; Nakasuka, Takamasa ; Kubo, Toshio...
Internal Medicine. 61 (2022) 3 - p. 379-383 , 2022

Link: https://doi.org/10.2169/..

14

Deciphering the clinical features of heterogeneous stage II..:

Murakami, Haruyasu ; Horinouchi, Hidehito ; Harada, Hideyuki...
Lung Cancer. 165 (2022) - p. 152-163 , 2022

Link: https://doi.org/10.1016/..

15

Identification of targetable kinases in idiopathic pulmonar..:

Higo, Hisao ; Ohashi, Kadoaki ; Tomida, Shuta...
Respiratory Research. 23 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..